The current pharma/bio market is a rapidly growing, high innovation market that has maintained exceptional growth over the past several years. Of the many technologies that have benefited from its rapid expansion, mass spectrometry has been at the forefront. The adoption of mass spectrometers has been particularly swift in proteomics and metabolomics applications. There are […]

Oil and gas infrastructure is a prime target for vandalism, thievery, and even sabotage. For years, countries, oil companies and fuel distributors have faced profit losses and property damage from individuals illegally tapping pipelines and selling the recovered oil or fuel in the black market. In some cases, criminal organizations have installed connections into the […]

Commercial testing labs play an important role in administering specialized environmental testing, with clients ranging from governmental agencies to corporate entities looking to meet regulatory burdens, health standards and to improve their environmental footprint. During the pandemic, these labs faced hardships as public and corporate funding was curtailed, impacting the overall environmental testing market. Now, […]

Implementing the appropriate laboratory instrumentation to support therapeutic development is crucial to the process of drug discovery. Life science and analytical instrumentation facilitates pharmaceutical R&D throughout these stages. SDi has observed the dynamics of the pharma/bio sector demand for instrumentation to support innovative biologics, small molecule drugs, regenerative pharmaceuticals, and biopharmaceuticals. Most of these drug […]

The servicing of analytical and life science instrumentation is vital to maintaining instrument performance capabilities and maximizing the life of costly lab assets.  Whether provided by the original instrument manufacturer or by a third-party service provider, the instrument service market includes all service contracts and any replacement parts installed during servicing. Other services like software […]

Clinical laboratory diagnostics has become an important area of investment and business transactions. Recently, Mesa Laboratories, a biotech company focused on quality control solutions for pharmaceutical, healthcare, and medical devices, announced the acquisition of Agena Bioscience for a cash purchase price of $300 million. According to the press release, Mesa is expected to pay for […]